visiongain Logo.png
Alzheimer’s Therapeutics market is projected to grow at a CAGR of 9.17% by 2032: Visiongain Reports Ltd
19 janv. 2023 11h45 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Alzheimer’s Therapeutics 2022-2032. It includes profiles of Alzheimer’s Therapeutics and Forecasts Market Segment by Drug (Donepezil, Rivastigmine,...
visiongain Logo.png
Alzheimer’s Therapeutics market is projected to grow at a CAGR of 9.17% by 2032: Visiongain Reports Ltd
13 déc. 2022 06h46 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Alzheimer’s Therapeutics 2022-2032. It includes profiles of Alzheimer’s Therapeutics and Forecasts Market Segment by Drug (Donepezil, Rivastigmine,...
FBI LOGO TM.png
Alzheimer’s Drugs Market Size [2022-2028] | Industry Size, Share, Growth, Trends & Forecast Analysis
05 mai 2022 07h28 HE | Fortune Business Insights
Pune, India, May 05, 2022 (GLOBE NEWSWIRE) -- Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer’s drugs which in turn is driving the global Alzheimer’s drugs market,...
visiongain Logo.png
Alzheimer’s Drugs Market Report to 2031: Visiongain Research Inc.
19 juil. 2021 09h00 HE | Visiongain Ltd
Visiongain has published a new report on Alzheimer’s Drugs Market Report to 2031: Forecasts by Drugs (Donepezil, Rivastigmine, Galantamine, and Memantine), By Distribution Channel (Hospital...
FBI LOGO TM.png
Alzheimer’s Drugs Market Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Report
14 juil. 2021 04h33 HE | Fortune Business Insights
Pune, India, July 14, 2021 (GLOBE NEWSWIRE) -- Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer’s drugs which in turn is driving the global Alzheimer’s drugs market,...
FBI LOGO TM.png
Alzheimer’s Drugs Market 2021 Size, Share, Growth, Trends, Analysis, Revenue, Competitive Landscape, Forecast Report 2021-2028
16 févr. 2021 05h47 HE | Fortune Business Insights
Pune, India, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer’s drugs which in turn is driving the global market, says Fortune...